Soy and Isoflavones Effect on Bone
Completed · Phase 4 · Has a placebo group
Conditions studied: Osteoporosis
In brief
The purpose of this study is to test the effect of 1 year of added dietary soy protein and/or soy isoflavones on bone mineral density in late postmenopausal women.
Key facts
- Study ID
- NCT00668447
- Run by
- United States Department of Agriculture (USDA)
- People needed
- 97
- Starts
- 2001-11-01
- Expected to finish
- 2005-06-01
- Last updated by the study team
- 2008-04-29
Who can join
Age: 65 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Postmenopausal women 65 years old or older
- Able to travel to the clinical sites for follow-up visits
You may not qualify if…
- History of disease that may affect bone metabolism (including Paget's disease, primary hyperparathyroidism, osteomalacia, untreated hyperthyroidism, or multiple myeloma)
- Cancer of any kind (except basal or squamous cell of skin) in past 5 years
- Use of any of the following medications within the past 2 years: calcitonin, calcitriol, heparin, phenytoin, phenobarbital
- Use at any time of bisphosphonates, long-term corticosteroids (over 6 months), methotrexate, or fluoride
- Estimated creatinine clearance less than 50 ml/min
- History of chronic liver disease or evidence of liver disease on screening
- History of hip fracture
- Known vertebral fracture within the past year
- Vegans
Where it is running
- University of Connecticut Health Center — Farmington, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.